Nizatidine (Glenmark Generics Inc.,USA)
Welcome to the PulseAid listing for the Nizatidine drug offered from Glenmark Generics Inc.,USA. This Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Glenmark Generics Inc.,USA |
NON-PROPRIETARY NAME: | Nizatidine |
SUBSTANCE NAME: | NIZATIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-07-15 |
END MARKETING DATE: | 0000-00-00 |
Nizatidine HUMAN PRESCRIPTION DRUG Details:
Item Description | Nizatidine from Glenmark Generics Inc.,USA |
LABELER NAME: | Glenmark Generics Inc.,USA |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2011-07-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68462-425_471123bb-f0b6-486b-b5f8-b0d3e06fe56c |
PRODUCT NDC: | 68462-425 |
APPLICATION NUMBER: | ANDA090618 |
Other NIZATIDINE Pharmaceutical Manufacturers / Labelers: